RxSight outlines $120M-$135M 2026 revenue guidance while strengthening commercial initiatives
Source: SeekingAlpha
2026-02-25 23:18:26 ET
More on RxSight
- RxSight, Inc. (RXST) Q4 2025 Earnings Call Transcript
- RxSight, Inc. (RXST) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- RxSight, Inc. (RXST) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- RxSight Non-GAAP EPS of -$0.03 beats by $0.17, revenue of $32.6M in-line
- RxSight guides FY revenue above previous estimates, names new CFO
Read the full article on Seeking Alpha
For further details see:
RxSight outlines $120M–$135M 2026 revenue guidance while strengthening commercial initiatives
RxSight Inc.
NASDAQ: RXST
RXST Trading
1.75% G/L:
$7.54 Last:
308,775 Volume:
$7.64 Open:
RXST Latest News
February 25, 2026 04:05:00 pm
RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance
February 11, 2026 04:10:00 pm
RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
RXST Stock Data
$337,567,614
37,181,778
N/A
47
N/A
Medical Equipment & Supplies
Healthcare
US
Aliso Viejo
